Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Dietrich, K.; Theobald, M.
Immunological tumor therapyINTERNIST. Bd. 56. H. 8. 2015 S. 907-916
Wehler, Thomas; Wehler, Beatrice; Stehle, Ingo
Immunotherapy in Lung Cancer Checkpoint-InhibitorsDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 140. H. 24. 2015 S. 1835-1838
Nestle, Ursula; Rischke, Hans Christian; Eschmann, Susanne Martina et al.
Improved inter-observer agreement of an expert review panel in an oncology treatment trial - Insights from a structured interventional processEUROPEAN JOURNAL OF CANCER. Bd. 51. H. 17. 2015 S. 2525-2533
Bussmann, Sonja; Muders, Pia; Zahrt-Omar, Corinna Aruna et al.
Improving End-of-Life Care in Hospitals: A Qualitative Analysis of Bereaved Families' Experiences and SuggestionsAMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE. Bd. 32. H. 1. 2015 S. 44-51
Ishibashi, Kei; Haber, Tobias; Kubo, Hitoshi et al.
Improving TKI efficiency by IL-6 inhibitionINTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. Bd. 36. 2015 S. S50-S50
Tulla, M.; Berthold, F.; Graf, N. et al.
Incidence, Trends, and Survival of Children With Embryonal TumorsPEDIATRICS. Bd. 136. H. 3. 2015 S. E623-E632
Roos, Frederik C.; Thomas, Christian
Indications for cytoreductive NephrectomyAKTUELLE UROLOGIE. Bd. 46. H. 2. 2015 S. 101-102
Fischer, T; Langanke, M; Michl, S et al.
Individualized Medicine. Ethical, Economical and Historical PerspectivesSpringer 2015 323 S.
Haehnel, P. S.; Sasca, D.; Enders, B. et al.
Inhibition of PARP selectively sensitizes KRAS-mutant cancer cells to chemotherapy in vivo - an updateOncology Research and Treatment. Bd. 38. 2015 S. 98-99
Hager, Benjamin; Kraywinkel, Klaus; Keck, Bastian et al.
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011RADIOTHERAPY AND ONCOLOGY. Bd. 115. H. 1. 2015 S. 90-95